KRAS mutation status concordance between the primary tumor and the corresponding metastasis in patients with rectal cancer-Reference-Cited by-同舟云学术

KRAS mutation status concordance between the primary tumor and the corresponding metastasis in patients with rectal cancer

Published:2020-10-01 Issue:10 Volume:15 Page:e0239806
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Jo Peter^ORCID,Bernhardt Markus,Nietert Manuel,König Alexander,Azizian Azadeh,Schirmer Markus A.,Grade Marian,Kitz Julia,Reuter-Jessen Kirsten,Ghadimi Michael,Ströbel Philipp,Schildhaus Hans-Ulrich,Gaedcke Jochen

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference45 articles.

1. Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer;E Van Cutsem;N Engl J Med,2009

2. KRAS mutations as an independent prognostic factor in patients with advanced colorectal cancer treated with cetuximab;A Lievre;Journal of clinical oncology: official journal of the American Society of Clinical Oncology,2008

3. Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer;RG Amado;Journal of clinical oncology: official journal of the American Society of Clinical Oncology,2008

4. K-ras mutations and benefit from cetuximab in advanced colorectal cancer;CS Karapetis;N Engl J Med,2008

5. KRAS mutation testing in colorectal cancer;TP Plesec;Advances in anatomic pathology,2009

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CHNet: A multi-task global–local Collaborative Hybrid Network for KRAS mutation status prediction in colorectal cancer;Artificial Intelligence in Medicine;2024-09

2. Biological factors driving colorectal cancer metastasis;World Journal of Gastrointestinal Oncology;2024-02-15

3. Irinotecan- vs. Oxaliplatin-Based Doublets in KRASG12C-Mutated Metastatic Colorectal Cancer—A Multicentre Propensity-Score-Matched Retrospective Analysis;Cancers;2023-06-05

4. Prognostic and Predictive Biomarkers in Patients with Locally Advanced Rectal Cancer (LARC) Treated with Preoperative Chemoradiotherapy;Journal of Clinical Medicine;2022-10-16

5. A segmentation-based sequence residual attention model for KRAS gene mutation status prediction in colorectal cancer;Applied Intelligence;2022-08-16